References
- Rando RR, Bernstein PS, Barry RJ. New insights into the visual cycle. In: Osborne N, Chader G, eds. Progress in Retinal Research. New York: Pergamon Press; 1990:161–178.
- Bridges CDB, Alvarez RA, Fong S-L, Gonzalez-Fernan-dez F, Lam DIVIK, Liou GI. Visual cycle in the mammalian eye: retinoid-binding proteins and the distribution of 11-cis retinoids. Vision Res. 1984;24: 1581–1594.
- Dowling SE. The organization of vertebrate visual recep-tors. In: Allen JM, ed. Molecular Organization, and Bio-logical Function. New York: Harper and Row; 1967:186–120.
- Schnedl WJ, Feber S, Johnsonn JH, Newgard CB. STZ transport and cytotoxicity: specific enhancement in GLUT-2 expressing cells. Diabetes. 1994;43:1326–1333.
- Ostroy SE, Frede SM, Wagner EF, Gaitatzes CG, Janie EM. Decreased rhodopsin regeneration in diabetic mouse eyes. Invest Ophthalmol Vis Sci. 1994;35:3905–3909.
- Coleman DL. Obese and diabetes: two mutant genes caus-ing diabetes-obesity syndromes in mice. Diabetologia. 1978;14:141–148.
- Lythgoe RJ, Quilliam JP. The relation of transient orange to visual purple and indicator yellow. J Physiol. 1938;94: 399–410.
- Abrahamson EW, Ostroy SE, eds. Benchmark Papers in Biochemistry/3. Molecular Processes in Vision. Strouds-burg, PA: Hutchinson Ross Publishing Co; 1981:431.
- Ostroy SE, Gaitatzes CG, Friedmann AL. Hypoxia inhibits rhodopsin regeneration in the excised mouse eye. Invest Ophthalmol Vis Sci. 1993;34:447–452.
- Ostroy SE, Friedmann AL, Gaitatzes CG. Extracellular glucose dependence of rhodopsin regeneration in the excised mouse eye. Exp Eye Res. 1992;55:419–423.
- Ratzlaff KO. Inhibition of rhodopsin regeneration in the bullfrog eye by metabolic inhibitors. Vision Res. 1975;15: 73–77.
- Macaluso C, Onoe S, Niemeyer C. Changes in glucose level affect rod function more than cone function in the isolated, perfused cat eye. Invest Ophthalmol Vis Sci. 1992; 33:2798–2808.
- Le PH, Leiter EH, Leyendecker JR. Genetic control of susceptibility to streptozotocin diabetes in inbred mice: Effect of testosterone and H-2 haplotype. Endocrinology. 1985;116: 2450–2455.
- Mitruka BM, Rawnsley RM. Clinical Biochemical and Hematological Reference Values in Normal Experimental Animals. New York: Masson Publishing USA, Inc.;1977.
- Pinto LH, Ostroy SE. Ionizable groups and conductances of the rod photoreceptor membrane. J Gen Physiol. 1978; 71:329–345.
- SAS/STAT User's Guide. Release 6.03 ed. Cary, NC: SAS Institute; 1988.
- Stryer L. Biochemistry, 4th ed. New York: WH Freeman & Co; 1995.
- Strupp M, Jund R, Schneider U, Grafe P. Glucose avail-ability and sensitivity to anoxia of isolated rat peroneal nerve. Am J Physiol. 1991;261:E389–E394.
- Wachtler J, Mayer C, Rucker F, Grafe P. Glucose availabil-ity alters ischaemia-induced changes in intracellular pH and calcium of isolated rat spinal roots. Brain Res. 1996; 725:30–36.
- Henson DB, North RV. Dark adaptation in diabetes mel-litus. Br J Ophthalmol. 1979;63:539–541.
- Papakostopoulos D, Hart JCD, Corrall RIM, Harney B. The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent dia-betes. Int J Psychophysiol. 1996;21:33–43.
- Lafond G, Quigley M, Zahjaria M, Brunette JR. The a and b-wave electroretinogram changes in diabetic retinopathy under light and dark adaptation. Invest Ophthalmol Vis Sci. 1997:38(suppl):4107.
- Palczewski K, Saari JC. Activation and inactivation steps in the visual transduction pathway. Curr Opin Neurobiol. 1997;7:500–504.
- Frank RN. Studies in diabetic retinopathy. In: Tso MOM, ed. Retinal Diseases: Biomedical Foundations and Clinical Man-agement. Philadelphia, PA: JB Lippincott; 1988:165–180.
- Cathelineau G, Cathelineau By. Diabetic retinopathy: methodologies in practice. Diabet Med. 1991;8:17–22.